| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $-0.56365 (Miss by $-0.75365) |
| EPS GAAP Actual | $-0.56365 (Miss by $-0.75365) |
| Revenue Actual | $-0.00084183B |
| Revenue Surprise | Beat by $-0.84183M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.41 |
| EPS GAAP Estimate | $0.41 |
| Revenue Estimate | $0.046187532B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 3.03 | 0.76 | 2.21941 | 3.95521 | 1 |
| Dec 2028 | 3.08 | 0.75 | 2.79523 | 3.35185 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.57 | -1.1 | -0.00084183B | 100% | -18.96M |
| FQ2 2025 (Jun 2025) | -0.6 | -1.11333 | 0.00514736B | 100% | -12.97M |
| FQ1 2025 (Mar 2025) | 0.18 | -0.32 | 0B | NAN% | -17.87M |
| FQ4 2024 (Dec 2024) | -0.0455 | -0.0455 | 0.00748538B | -133.15% | 7.49M |
| FQ3 2024 (Sep 2024) | 0.0669 | 0.0669 | 0B | NAN% | 0M |
| FQ3 2020 (Sep 2020) | 0.39 | 0.39 | 0.00159477B | 100% | 1.59M |
| FQ2 2024 (Jun 2024) | 0.81 | 0.81 | 0B | -INF% | 0M |
| FQ1 2024 (Mar 2024) | -0.0027 | -0.0027 | 0B | -INF% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.41
Consensus Revenue Estimates
0.046187532B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.18 | -- | 0.16649 | 0.19038 | 1 |
| FQ3 2027 (Sep 2027) | 0.33 | -- | 0.21956 | 0.39071 | 1 |
| FQ2 2027 (Jun 2027) | 0.32 | -- | 0.21291 | 0.37887 | 1 |
| FQ1 2027 (Mar 2027) | 0.31 | -- | 0.20625 | 0.36703 | 1 |
| FQ4 2026 (Dec 2026) | 0.47 | -- | 0.3478 | 0.59723 | 0 |
| FQ3 2026 (Sep 2026) | 0.45 | 226.67 | 0.333 | 0.57181 | 0 |
| FQ2 2026 (Jun 2026) | 0.43 | 239.53 | 0.3182 | 0.5464 | 0 |
| FQ1 2026 (Mar 2026) | 0.41 | 56.1 | 0.3034 | 0.52099 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2027 (Sep 2027) | 0.02B | -- | 0.01B | 0.02B | 1 |
| FQ2 2027 (Jun 2027) | 0.02B | -- | 0.01B | 0.02B | 1 |
| FQ1 2027 (Mar 2027) | 0.01B | -- | 0.01B | 0.02B | 1 |
| FQ4 2026 (Dec 2026) | 0.07B | -- | 0.05B | 0.08B | 1 |
| FQ3 2026 (Sep 2026) | 0.06B | 101.43 | 0.05B | 0.07B | 1 |
| FQ2 2026 (Jun 2026) | 0.05B | 90.11 | 0.04B | 0.06B | 1 |
| FQ1 2026 (Mar 2026) | 0.05B | -- | 0.04B | 0.06B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
2
Revenue # of Misses
3
Revenue # of in-lines
3
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.53 | -0.57 | -1.1 | 192.98% |
| FQ2 2025 (Jun 2025) | 0.51333 | -0.6 | -1.11333 | 185.56% |
| FQ1 2025 (Mar 2025) | 0.5 | 0.18 | -0.32 | -177.78% |
| FQ4 2024 (Dec 2024) | -0.0455 | -0.0455 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0669 | 0.0669 | 100% | |
| FQ3 2020 (Sep 2020) | 0.39 | 0.39 | 100% | |
| FQ2 2024 (Jun 2024) | 0.81 | 0.81 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0027 | -0.0027 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.02B | $-0B | $-18.96M | 2251.98% |
| FQ2 2025 (Jun 2025) | $0.02B | $0.01B | $-12.97M | -251.95% |
| FQ1 2025 (Mar 2025) | $0.02B | $0B | $-17.87M | -INF% |
| FQ4 2024 (Dec 2024) | $0B | $0.01B | $7.49M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2020 (Sep 2020) | $0B | $0B | $1.59M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |